Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Holtzman

Showing results (191-200 of 604) with videos related to

Pageof 61
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 10, 2010
Beta-secretase inhibitor GRL-8234 rescues age-related cognitive decline in APP transgenic miceWan-Pin Chang, Xiangping Huang, Deborah Downs, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 1, 2008
Ceramide is responsible for the failure of compensatory nerve sprouting in apolipoprotein E knock-out miceDusica Maysinger, Michael Holmes, Xianlin Han, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 16, 2005
IgG-assisted age-dependent clearance of Alzheimer's amyloid beta peptide by the blood-brain barrier neonatal Fc receptorRashid Deane, Abhay Sagare, Katie Hamm, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|November 2, 2006
Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous systemRobert D Bell, Abhay P Sagare, Alan E Friedman, et al.
Journal of Alzheimer'S Disease : JAD|April 29, 2017
Neuropsychiatric Symptoms and Alzheimer's Disease Biomarkers Predict Driving Decline: Brief ReportGanesh M Babulal, Sarah H Stout, Denise Head, et al.
JAMA Neurology|August 23, 2016
Longitudinal β-Amyloid Deposition and Hippocampal Volume in Preclinical Alzheimer Disease and Suspected Non-Alzheimer Disease PathophysiologyBrian A Gordon, Tyler Blazey, Yi Su, et al.
JAMA Neurology|April 14, 2015
Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer DiseaseRawan Tarawneh, Denise Head, Samantha Allison, et al.
Alzheimer Disease and Associated Disorders|December 14, 2011
Cerebrospinal fluid proteins predict longitudinal hippocampal degeneration in early-stage dementia of the Alzheimer typeLei Wang, Anne M Fagan, Aarti R Shah, et al.
Sleep Advances : a Journal of the Sleep Research Society|May 7, 2024
Midpoint of sleep is associated with sleep quality in older adults with and without symptomatic Alzheimer's diseaseScott C Sauers, Cristina D Toedebusch, Rachel Richardson, et al.
Journal of the Neurological Sciences|March 12, 2005
Matrix metalloproteinase-9 in cerebral-amyloid-angiopathy-related hemorrhageJin-Moo Lee, Kejie Yin, Idar Hsin, et al.
Pageof 61

Showing results (191-200 of 604) with videos related to

Sort By:
Pageof 61
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 10, 2010
Beta-secretase inhibitor GRL-8234 rescues age-related cognitive decline in APP transgenic miceWan-Pin Chang, Xiangping Huang, Deborah Downs, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 1, 2008
Ceramide is responsible for the failure of compensatory nerve sprouting in apolipoprotein E knock-out miceDusica Maysinger, Michael Holmes, Xianlin Han, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 16, 2005
IgG-assisted age-dependent clearance of Alzheimer's amyloid beta peptide by the blood-brain barrier neonatal Fc receptorRashid Deane, Abhay Sagare, Katie Hamm, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|November 2, 2006
Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous systemRobert D Bell, Abhay P Sagare, Alan E Friedman, et al.
Journal of Alzheimer'S Disease : JAD|April 29, 2017
Neuropsychiatric Symptoms and Alzheimer's Disease Biomarkers Predict Driving Decline: Brief ReportGanesh M Babulal, Sarah H Stout, Denise Head, et al.
JAMA Neurology|August 23, 2016
Longitudinal β-Amyloid Deposition and Hippocampal Volume in Preclinical Alzheimer Disease and Suspected Non-Alzheimer Disease PathophysiologyBrian A Gordon, Tyler Blazey, Yi Su, et al.
JAMA Neurology|April 14, 2015
Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer DiseaseRawan Tarawneh, Denise Head, Samantha Allison, et al.
Alzheimer Disease and Associated Disorders|December 14, 2011
Cerebrospinal fluid proteins predict longitudinal hippocampal degeneration in early-stage dementia of the Alzheimer typeLei Wang, Anne M Fagan, Aarti R Shah, et al.
Sleep Advances : a Journal of the Sleep Research Society|May 7, 2024
Midpoint of sleep is associated with sleep quality in older adults with and without symptomatic Alzheimer's diseaseScott C Sauers, Cristina D Toedebusch, Rachel Richardson, et al.
Journal of the Neurological Sciences|March 12, 2005
Matrix metalloproteinase-9 in cerebral-amyloid-angiopathy-related hemorrhageJin-Moo Lee, Kejie Yin, Idar Hsin, et al.
Pageof 61